
The pharmaceutical industry is a robust and continually evolving sector, poised for sustained growth in the coming years, driven by several factors, including an aging global population, the rising incidence of chronic illnesses, and technological advancements.
Considering the solid industry prospects, I think Teva Pharmaceutical Industries Limited (TEVA), Eli Lilly and Company (LLY), and Merck & Co., Inc. (MRK) could be quality buys now.